Two Sigma Securities, LLC Equillium, Inc. Transaction History

Two Sigma Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.72 - $0.9 $26,126 - $32,658	36,287 New	36,287 $26,000
Q2 2022 Aug 15, 2022	SELL	$1.69 - $3.26 $20,935 - $40,384	-12,388 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.99 - $4.19 $84,449 - $118,342	-28,244 Reduced 69.51%	12,388 $39,000
Q4 2021 Feb 14, 2022	SELL	$3.77 - $6.99 $163,301 - $302,778	-43,316 Reduced 51.6%	40,632 $153,000
Q3 2021 Nov 15, 2021	BUY	$4.84 - $6.91 $406,308 - $580,080	83,948 New	83,948 $573,000

11.5M

38.1K

Ticker EQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,352,100
Market Cap $47.1M
Description
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.